EC Number   |
Activating Compound |
Reference |
|---|
    1.4.3.3 | (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine |
MK-801, a dose-dependent elevation in the expression of DAO mRNA is observed in most brain areas 4 h after the administration (1.6 mg/kg) |
679665 |
| 1.4.3.3 | 2,3-Butanedione |
115% activity at 10 mM |
741688 |
| 1.4.3.3 | D-amino acid oxidase activator |
i.e. DAOA or G72, the gene encoding the activator is located on chromosome 13q32-34 |
699646 |
| 1.4.3.3 | D-malate |
107% activity at 10 mM |
741688 |
| 1.4.3.3 | DAO activator |
DAOA, formerly G72 |
684296 |
| 1.4.3.3 | G72 protein |
- |
686069 |
| 1.4.3.3 | iodoacetate |
112% activity at 10 mM |
741688 |
| 1.4.3.3 | more |
activity of the DAAO after incubation in water-insoluble ionic liquids is higher than in water-soluble ones |
674970 |
| 1.4.3.3 | more |
exogenous FAD (0.01 to 1 mM) added to assay or protein storage buffers does not enhance the catalytic activity of native and recombinant DAO |
671491 |
| 1.4.3.3 | more |
L5/L6 spinal nerve ligation in the lumbar spinal cord increases the enzyme activity with an increase in neuropathic pain, mechanical allodynia |
699761 |
